These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2411050)

  • 1. Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.
    Katoh I; Yoshinaka Y; Rein A; Shibuya M; Odaka T; Oroszlan S
    Virology; 1985 Sep; 145(2):280-92. PubMed ID: 2411050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
    Fan H; Chute H; Chao E; Feuerman M
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5965-9. PubMed ID: 6310608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
    Crawford S; Goff SP
    J Virol; 1985 Mar; 53(3):899-907. PubMed ID: 3882995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon.
    Yoshinaka Y; Katoh I; Copeland TD; Oroszlan S
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1618-22. PubMed ID: 3885215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease bypass of temperature-sensitive murine leukemia virus maturation mutants.
    Traktman P; Baltimore D
    J Virol; 1982 Dec; 44(3):1039-46. PubMed ID: 6184485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease.
    Yoshinaka Y; Katoh I; Copeland TD; Oroszlan S
    J Virol; 1985 Sep; 55(3):870-3. PubMed ID: 2991607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.
    Kohl NE; Diehl RE; Rands E; Davis LJ; Hanobik MG; Wolanski B; Dixon RA
    J Virol; 1991 Jun; 65(6):3007-14. PubMed ID: 1709693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization.
    Rein AL; Gerwin BI; Bassin RH; Schwarm L; Schidlovsky G
    J Virol; 1978 Jan; 25(1):146-56. PubMed ID: 74421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events.
    Schultz AM; Rein A
    J Virol; 1989 May; 63(5):2370-3. PubMed ID: 2649693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus.
    Hsu HW; Schwartzberg P; Goff SP
    Virology; 1985 Apr; 142(1):211-4. PubMed ID: 2414902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.
    Yeager M; Wilson-Kubalek EM; Weiner SG; Brown PO; Rein A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7299-304. PubMed ID: 9636143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure.
    Levin JG; Hu SC; Rein A; Messer LI; Gerwin BI
    J Virol; 1984 Aug; 51(2):470-8. PubMed ID: 6205170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity.
    Housset V; Darlix JL
    C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity and structure of molecular clones obtained from two genetically transmitted Moloney leukemia proviral genomes.
    Harbers K; Schnieke A; Stuhlmann H; Jaenisch R
    Nucleic Acids Res; 1982 Apr; 10(8):2521-37. PubMed ID: 6281733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule.
    Gerwin BI; Rein A; Levin JG; Bassin RH; Benjers BM; Kashmiri SV; Hopkins D; O'Neill BJ
    J Virol; 1979 Sep; 31(3):741-51. PubMed ID: 92571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin.
    Ikuta K; Luftig RB
    Virology; 1986 Oct; 154(1):195-206. PubMed ID: 3489314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein.
    McDermott J; Karanjia S; Love Z; Barklis E
    Virology; 2000 Mar; 269(1):190-200. PubMed ID: 10725211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of formation of suppressor glutamine tRNA in Moloney murine leukemia virus-infected NIH-3T3 cells by Avarol.
    Kuchino Y; Nishimura S; Schröder HC; Rottmann M; Müller WE
    Virology; 1988 Aug; 165(2):518-26. PubMed ID: 2457280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
    Li KJ; Garoff H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdominant inhibition of Moloney murine leukemia virus proliferation by defective mutants of reverse transcriptase.
    Shirasawa Y; Sato S; Osawa T; Hirashima A
    J Biochem; 1996 Jun; 119(6):1070-5. PubMed ID: 8827439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.